Mercury Laboratories Ltd Financials

Mercury Laboratories Ltd Financial Statement

Mercury Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Dec 2024	Sep 2024	Jun 2024
Revenue	20.10	18.40	16.83
Operating Expense	17.60	16.88	15.07
Net Profit	1.19	0.50	0.34
Net Profit Margin	5.92	2.72	2.02
Earning Per Share	9.94	4.17	2.85
EBIDTA	2.75	1.73	1.58
Effective Tax Rate	27.49	24.34	22.73

Particulars	Dec 2024
Revenue	20.10
Operating Expense	17.60
Net Profit	1.19
Net Profit Margin	5.92
Earning Per Share	9.94
EBIDTA	2.75
Effective Tax Rate	27.49

Mercury Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	75.56	75.33	57.92
Operating Expenses Annual	66.53	66.76	50.93
Operating Profit Annual	10.12	10.29	7.93
Interest Annual	0.38	0.36	0.45
Depreciation	2.80	2.46	2.45
Net Profit Annual	5.65	5.58	3.56
Tax Annual	1.27	1.87	1.47

Particulars	Mar 2024
Total Revenue Annual	75.56
Operating Expenses Annual	66.53
Operating Profit Annual	10.12
Interest Annual	0.38
Depreciation	2.80
Net Profit Annual	5.65
Tax Annual	1.27

Mercury Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	7.32	6.93	4.87
Cash Flow from Operations	8.23	2.45	5.19
Cash Flow from Investing	-6.27	-1.06	-1.89
Cash Flow from Financing	-1.04	-1.01	-1.23
Cash Flow at the End	8.23	7.32	6.93

Particulars	Mar 2024
Cash Flow at the Beginning	7.32
Cash Flow from Operations	8.23
Cash Flow from Investing	-6.27
Cash Flow from Financing	-1.04
Cash Flow at the End	8.23

Mercury Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	13.39	13.66	13.71
PBIT Margin (%)	9.66	10.37	9.48
PBT Margin (%)	-15.76	-18.42	-11.55
Net PROFIT Margin (%)	7.48	7.41	6.15
Return On Networth / Equity (%)	11.71	12.99	9.22
Return On Networth /Employed (%)	13.54	15.78	11.81
Return On Assets (%)	10.47	11.26	7.68
Total Debt / Equity (X)	0.12	0.14	0.17
Asset Turnover Ratio (%)	1.40	1.52	1.25

Particulars	Mar 2024
PBDIT Margin (%)	13.39
PBIT Margin (%)	9.66
PBT Margin (%)	-15.76
Net PROFIT Margin (%)	7.48
Return On Networth / Equity (%)	11.71
Return On Networth /Employed (%)	13.54
Return On Assets (%)	10.47
Total Debt / Equity (X)	0.12
Asset Turnover Ratio (%)	1.40

Mercury Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	24.03	24.26	25.82
Total Current Assets Annual	39.84	39.46	35.22
Non Current Assets Annual	28.12	24.71	27.21
Total Shareholders Funds Annual	50.84	45.63	40.31
Total Assets Annual	67.96	64.16	62.43

Particulars	Mar 2024
Fixed Assets Annual	24.03
Total Current Assets Annual	39.84
Non Current Assets Annual	28.12
Total Shareholders Funds Annual	50.84
Total Assets Annual	67.96

Mercury Laboratories Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Mercury Laboratories Ltd Financials

As of Feb 22, 2025, Mercury Laboratories Ltd has a market capitalization of 99.85 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Mercury Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.11.

In FY 2024 , Mercury Laboratories Ltd recorded a total revenue of approximately 75.56 Cr marking a significant milestone in the company's financial performance.

Mercury Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.1% annually, respectively..

Mercury Laboratories Ltd's current PE ratio is 17.67.

Mercury Laboratories Ltd's ROCE averaged 13.3% from the FY ending March 2022 to 2024, with a median of 13.0%. It peaked at 15.2% in March 2023, reflecting strong capital efficiency over the period..

Mercury Laboratories Ltd's latest EBIT is Rs. 7.30 Cr, surpassing the average EBIT of Rs. 6.86 Cr over the 5 years..